Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ECG NYSE:EE NASDAQ:TMDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECGEverus Construction Group$136.91-1.3%$151.93$65.27▼$171.58$6.99B2.23658,604 shs376,570 shsEEExcelerate Energy$38.92+1.5%$35.30$21.28▼$43.17$4.43B1.23425,938 shs158,833 shsTMDXTransMedics Group$71.23-1.3%$72.06$60.10▼$156.00$2.46B1.891.10 million shs455,584 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECGEverus Construction Group+3.44%-0.02%-5.34%+6.51%+106.37%EEExcelerate Energy-3.14%+0.98%+19.20%+11.24%+38.11%TMDXTransMedics Group+2.48%+4.84%-2.83%-36.68%-42.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECGEverus Construction Group$136.91-1.3%$151.93$65.27▼$171.58$6.99B2.23658,604 shs376,570 shsEEExcelerate Energy$38.92+1.5%$35.30$21.28▼$43.17$4.43B1.23425,938 shs158,833 shsTMDXTransMedics Group$71.23-1.3%$72.06$60.10▼$156.00$2.46B1.891.10 million shs455,584 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECGEverus Construction Group+3.44%-0.02%-5.34%+6.51%+106.37%EEExcelerate Energy-3.14%+0.98%+19.20%+11.24%+38.11%TMDXTransMedics Group+2.48%+4.84%-2.83%-36.68%-42.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECGEverus Construction Group 2.56Moderate Buy$155.6713.70% UpsideEEExcelerate Energy 2.62Moderate Buy$39.000.21% UpsideTMDXTransMedics Group 2.38Hold$134.5088.82% UpsideCurrent Analyst Ratings BreakdownLatest TMDX, EE, and ECG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026EEExcelerate Energy StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$45.007/6/2026TMDXTransMedics Group Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/1/2026TMDXTransMedics Group TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$120.006/30/2026TMDXTransMedics Group Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$124.006/24/2026EEExcelerate Energy Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)6/18/2026TMDXTransMedics Group Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$75.00 ➝ $80.006/15/2026ECGEverus Construction Group Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy6/9/2026TMDXTransMedics Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)5/28/2026ECGEverus Construction Group OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$185.005/26/2026TMDXTransMedics Group UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold5/26/2026TMDXTransMedics Group Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$85.00 ➝ $75.00(Data available from 7/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECGEverus Construction Group$3.96B1.77$4.64 per share29.51$12.35 per share11.09EEExcelerate Energy$1.23B3.61$1.77 per share21.95$19.55 per share1.99TMDXTransMedics Group$605.49M4.07$3.97 per share17.94$13.79 per share5.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECGEverus Construction Group$201.77M$4.3631.4028.58N/A5.65%37.17%13.38%8/11/2026 (Estimated)EEExcelerate Energy$39.20M$1.2331.6419.561.442.98%3.85%2.07%8/5/2026 (Confirmed)TMDXTransMedics Group$190.29M$4.4016.1920.24N/A27.04%22.38%8.46%7/30/2026 (Estimated)Latest TMDX, EE, and ECG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026EEExcelerate Energy$0.35N/AN/AN/A$363.99 millionN/A7/30/2026Q2 2026TMDXTransMedics Group$0.51N/AN/AN/A$184.57 millionN/A5/6/2026Q1 2026EEExcelerate Energy$0.39$0.37-$0.02$0.37$351.68 million$433.44 million5/5/2026Q1 2026ECGEverus Construction Group$0.8140$1.14+$0.3260$1.14$933.81 million$1.04 billion5/5/2026Q1 2026TMDXTransMedics Group$0.62$0.30-$0.32$0.20$174.44 million$173.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthECGEverus Construction GroupN/AN/AN/AN/AN/AEEExcelerate Energy$0.320.82%N/A26.02%2 YearsTMDXTransMedics GroupN/AN/AN/AN/AN/ALatest TMDX, EE, and ECG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2026EEExcelerate Energyquarterly$0.080.9%5/20/20265/20/20266/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECGEverus Construction Group0.381.771.71EEExcelerate Energy0.532.602.60TMDXTransMedics Group1.706.746.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECGEverus Construction GroupN/AEEExcelerate Energy21.79%TMDXTransMedics Group99.67%Insider OwnershipCompanyInsider OwnershipECGEverus Construction Group0.33%EEExcelerate Energy2.34%TMDXTransMedics Group6.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECGEverus Construction Group10,00051.04 million50.87 millionN/AEEExcelerate Energy1,046113.86 million111.20 millionOptionableTMDXTransMedics Group21034.56 million32.18 millionOptionableTMDX, EE, and ECG HeadlinesRecent News About These CompaniesIs TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?July 8 at 1:46 PM | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Daiichi Sankyo Company (OtherDSKYF), Vertex Pharmaceuticals (VRTX) and TransMedics Group (TMDX)July 8 at 8:45 AM | theglobeandmail.comTransMedics Completes PAD Aviation Investment to Expand in EuropeJuly 7 at 1:45 PM | zacks.comTransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbHJuly 6, 2026 | prnewswire.comWhere Will TransMedics Group Stock Be in 10 Years?July 3, 2026 | fool.comTMDX stock rallies as analyst sees 77% upside — here’s whyJuly 1, 2026 | msn.comTransMedics: The Margins Must RecoverJuly 1, 2026 | seekingalpha.comReasons to Retain TransMedics Stock in Your Portfolio for NowJune 30, 2026 | zacks.comTransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Canaccord Genuity GroupJune 30, 2026 | marketbeat.comWhat a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropJune 25, 2026 | theglobeandmail.comVirtu Financial LLC Buys 22,202 Shares of TransMedics Group, Inc. $TMDXJune 19, 2026 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Price Target Raised to $80.00June 18, 2026 | marketbeat.comInsider Selling: TransMedics Group (NASDAQ:TMDX) Director Sells 9,624 Shares of StockJune 18, 2026 | insidertrades.comJohnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP InvestmentsJune 12, 2026 | globenewswire.comTransMedics Group Inc.June 11, 2026 | barrons.comTransMedics: Why I'm Still Bullish After The CollapseJune 9, 2026 | seekingalpha.comAnalysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)June 6, 2026 | theglobeandmail.comWill Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?June 6, 2026 | uk.finance.yahoo.comTransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock Conference - SlideshowJune 4, 2026 | seekingalpha.comTransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?June 4, 2026 | zacks.comReasons to Retain TransMedics Stock in Your Portfolio for NowMay 28, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026Microsoft Just Gave Investors 3 Dates They Can't Afford to IgnoreBy Chris Markoch | June 11, 20263 Tech ETFs That Could Bounce Back After the AI SelloffBy Nathan Reiff | June 20, 2026Why These 2 Hotel Stocks Are Beating Travel PeersBy Dan Schmidt | June 13, 2026TMDX, EE, and ECG Company DescriptionsEverus Construction Group NYSE:ECG$136.90 -1.74 (-1.25%) Closing price 03:59 PM EasternExtended Trading$136.64 -0.27 (-0.19%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers. Everus Construction Group is based in BISMARCK, N.D.Excelerate Energy NYSE:EE$38.92 +0.59 (+1.54%) Closing price 03:59 PM EasternExtended Trading$38.52 -0.41 (-1.04%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Excelerate Energy, Inc. provides flexible liquefied natural gas (LNG) solutions worldwide. The company offers regasification services, including floating storage and regasification units (FSRUs), infrastructure development, and LNG and natural gas supply, procurement, and distribution services; LNG terminal services; and natural gas supply to-power projects. Excelerate Energy, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas. Excelerate Energy, Inc. is a subsidiary of Excelerate Energy Holdings, LLC.TransMedics Group NASDAQ:TMDX$71.23 -0.96 (-1.33%) Closing price 04:00 PM EasternExtended Trading$71.03 -0.20 (-0.28%) As of 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab’s Stock Drop Comes With a Bullish Twist Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth PepsiCo’s Dividend Could Turn Patience Into Real Profit Lockheed Martin Secures the Ultimate Defense Moat Why Levi's Digital Strategy Is Paying Off in a Big Way Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
